Ebixa

Ebixa

memantine

Manufacturer:

Lundbeck

Distributor:

B L Hua
Concise Prescribing Info
Contents
Memantine HCl
Indications/Uses
Moderate to severe Alzheimer's disease.
Dosage/Direction for Use
Adult 5 mg/day on the 1st wk, 10 mg/day on the 2nd wk, then 15 mg/day on the 3rd wk. From the 4th wk on, treatment can be continued w/ the recommended maintenance dose of 20 mg/day. Max: 20 mg/day. Elderly 20 mg/day.
Administration
May be taken with or without food.
Special Precautions
Epilepsy. Co-administration w/ N-methyl-D-aspartate (NMDA)-antagonists (eg, amantadine, ketamine or dextromethorphan). Careful monitoring of patients w/ factors that may raise urine pH. Recent MI, uncompensated CHF, uncontrolled HTN. Pregnancy & lactation.
Adverse Reactions
Agitation, inflicted injury, urinary incontinence, diarrhoea, insomnia, dizziness, headache, hallucinations, fall, constipation, coughing, tiredness.
Drug Interactions
Levodopa, dopaminergic agonists, anticholinergics, barbiturates, neuroleptics, antispasmodic agents (dantrolene or baclofen), phenytoin, cimetidine, ranitidine, procainamide, quinidine, quinine, nicotine, hydrochlorothiazide. Avoid administration w/ amantadine, ketamine & dextromethorphan.
ATC Classification
N06DX01 - memantine ; Belongs to the class of other anti-dementia drugs.
Presentation/Packing
Form
Ebixa FC tab 10 mg
Packing/Price
28's
Form
Ebixa FC tab 20 mg
Packing/Price
28's
Form
Ebixa oral soln 5 mg/pump actuation
Packing/Price
100 mL x 1's;50 mL x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in